Home  >  News
Eppen_CellXpert_Nov24
you can get e-magazine links on WhatsApp. Click here
News
  Ribo and Ribocure enter exclusive global licensing agreement with Madrigal for novel siRNA therapeutics targeting MASH,   February 12, 2026
  Sanofi completes the acquisition of Dynavax Technologies,   February 12, 2026
  Sobi completes acquisition of Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout,   February 11, 2026
  US FDA accepts and grants priority review status to Takeda’s oveporexton for the treatment of narcolepsy type 1,   February 11, 2026
  Sanofi’s rilzabrutinib receives US FDA breakthrough therapy & Japanese orphan drug designations to treat warm autoimmune haemolytic anaemia,   February 11, 2026
  China NMPA designates priority review status to Eisai’s BLA for subcutaneous formulation of Leqembi to treat Alzheimer’s disease,   February 10, 2026
  Lilly to acquire biotech company, Orna Therapeutics to advance cell therapies,   February 10, 2026
  China NMPA approves Kelun-Biotech’s new indication application for TROP2-directed ADC sac-TMT to treat unresectable or metastatic HR+/HER2- breast cancer,   February 09, 2026
  US FDA intends to take action against non-FDA-approved GLP-1 drugs,   February 09, 2026
  US FDA approves label update for Kite’s Yescarta for R/R primary central nervous system lymphoma,   February 09, 2026
  US FDA grants priority review status to Pfizer’s Hympavzi sBLA to treat two haemophilia A or B patient populations with significant medical need,   February 09, 2026
  Partner Therapeutics’ zenocutuzumab-zbco receives US FDA Orphan Drug Designation for treatment of cholangiocarcinoma,   February 07, 2026
  Mirum Pharma receives Health Canada authorization for maralixibat to treat cholestatic pruritus in patients with Alagille syndrome,   February 07, 2026
  Evogene, Shanghai Lishan Biopharma ink exclusive worldwide licensing agreement for BMC128,   February 07, 2026
  UK MHRA updates guidance for semaglutide prescribers and patients,   February 07, 2026
  Pfizer launches cost savings programme on TrumpRx lowering drug costs for millions of Americans,   February 07, 2026
  GSK’s Nucala receives European Commission approval to treat chronic obstructive pulmonary disease,   February 07, 2026
  Balt’s Squid liquid embolic receives US FDA approval for adjunctive treatment for chronic subdural hematomas,   February 06, 2026
  Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica,   February 06, 2026
  OPKO Health, Entera Bio expand collaboration and license agreement to advance the first oral long-acting PTH analog,   February 06, 2026

  • Results Found: 22466
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 1124
 Back
 
Avians_2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram